Published in Biochem Pharmacol on December 11, 1991
Electrochemotherapy: aspects of preclinical development and early clinical experience. Ann Surg (2007) 1.85
A quantitative study of electroporation showing a plateau in net molecular transport. Biophys J (1993) 1.25
Increased platinum accumulation in SA-1 tumour cells after in vivo electrochemotherapy with cisplatin. Br J Cancer (1999) 1.05
Treatment of cancer with cryochemotherapy. Br J Cancer (2002) 1.05
Electrochemotherapy with bleomycin induces hallmarks of immunogenic cell death in murine colon cancer cells. Oncoimmunology (2014) 1.04
Quantitative study of molecular transport due to electroporation: uptake of bovine serum albumin by erythrocyte ghosts. Biophys J (1994) 1.03
The human carnitine transporter SLC22A16 mediates high affinity uptake of the anticancer polyamine analogue bleomycin-A5. J Biol Chem (2009) 0.99
Adenovirus dodecahedron, as a drug delivery vector. PLoS One (2009) 0.89
Basic features of a cell electroporation model: illustrative behavior for two very different pulses. J Membr Biol (2014) 0.89
In vivo evolution of tumour cells after the generation of double-strand DNA breaks. Br J Cancer (2003) 0.87
Electrochemotherapy for colorectal cancer with commonly used chemotherapeutic agents in a mouse model. Dig Dis Sci (2000) 0.86
Photochemical internalization of bleomycin for glioma treatment. J Biomed Opt (2012) 0.86
Dynamics of bleomycin interaction with a strongly bound hairpin DNA substrate, and implications for cleavage of the bound DNA. J Am Chem Soc (2012) 0.84
Mass Transfer Model for Drug Delivery in Tissue Cells with Reversible Electroporation. Int J Heat Mass Transf (2008) 0.82
Comparative roles of the cell wall and cell membrane in limiting uptake of xenobiotic molecules by Saccharomyces cerevisiae. Antimicrob Agents Chemother (2003) 0.81
Cytotoxic effects of topotecan combined with various active G2/M-phase anticancer drugs in human tumor-derived cell lines. Invest New Drugs (2000) 0.81
Impact of external medium conductivity on cell membrane electropermeabilization by microsecond and nanosecond electric pulses. Sci Rep (2016) 0.80
Electric pulses: a flexible tool to manipulate cytosolic calcium concentrations and generate spontaneous-like calcium oscillations in mesenchymal stem cells. Sci Rep (2016) 0.80
Increased doxorubicin uptake and toxicity in multicellular tumour spheroids treated with DC electrical fields. Br J Cancer (1999) 0.78
Photochemical internalization-mediated delivery of chemotherapeutic agents in human breast tumor cell lines. J Environ Pathol Toxicol Oncol (2012) 0.77
Electroporation increases antitumoral efficacy of the bcl-2 antisense G3139 and chemotherapy in a human melanoma xenograft. J Transl Med (2011) 0.77
The promising alliance of anti-cancer electrochemotherapy with immunotherapy. Cancer Metastasis Rev (2016) 0.77
Combined cytogenotoxic effects of bee venom and bleomycin on rat lymphocytes: an in vitro study. Biomed Res Int (2014) 0.75
Electroporation of DC-3F cells is a dual process. Biophys J (2015) 0.75
Sonochemotherapy of breast adenocarcinoma: an experimental in vivo model. J Ultrasound (2014) 0.75
Electrochemotherapy in pancreatic adenocarcinoma treatment: pre-clinical and clinical studies. Radiol Oncol (2016) 0.75
Functional annotation of chemical libraries across diverse biological processes. Nat Chem Biol (2017) 0.75
Dependence of Electroporation Detection Threshold on Cell Radius: An Explanation to Observations Non Compatible with Schwan's Equation Model. J Membr Biol (2016) 0.75
Synergistic effect of electric pulses and bleomycin on cultured rabbit subconjunctival fibroblasts. Graefes Arch Clin Exp Ophthalmol (1998) 0.75
Electropermeabilization of Inner and Outer Cell Membranes with Microsecond Pulsed Electric Fields: Quantitative Study with Calcium Ions. Sci Rep (2017) 0.75
Centriole disassembly in vivo and its effect on centrosome structure and function in vertebrate cells. J Cell Biol (1998) 2.92
Electrochemotherapy potentiation of antitumour effect of bleomycin by local electric pulses. Eur J Cancer (1991) 2.79
Effective treatment of cutaneous and subcutaneous malignant tumours by electrochemotherapy. Br J Cancer (1998) 2.11
Transient electropermeabilization of cells in culture. Increase of the cytotoxicity of anticancer drugs. Biochem Pharmacol (1988) 1.91
Electrochemotherapy, a new antitumor treatment. First clinical phase I-II trial. Cancer (1993) 1.90
A validated model of in vivo electric field distribution in tissues for electrochemotherapy and for DNA electrotransfer for gene therapy. Biochim Biophys Acta (2000) 1.83
Bleomycin, an apoptosis-mimetic drug that induces two types of cell death depending on the number of molecules internalized. Cancer Res (1993) 1.74
Cell electropermeabilization: a new tool for biochemical and pharmacological studies. Biochim Biophys Acta (1993) 1.61
Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60
[Electrochemotherapy, a new antitumor treatment: first clinical trial]. C R Acad Sci III (1991) 1.52
Fast kinetics of calcium release induced by myo-inositol trisphosphate in permeabilized rat hepatocytes. J Biol Chem (1989) 1.48
Electropermeabilization of cells in tissues assessed by the qualitative and quantitative electroloading of bleomycin. Biochim Biophys Acta (1994) 1.42
Observation of a centrality-dependent dijet asymmetry in lead-lead collisions at sqrt[S(NN)] =2.76 TeV with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.41
Phase I/II trial for the treatment of cutaneous and subcutaneous tumors using electrochemotherapy. Cancer (1996) 1.41
Measurement of dijet azimuthal decorrelations in pp collisions at sqrt(s)=7 TeV. Phys Rev Lett (2011) 1.39
Efficiency of high- and low-voltage pulse combinations for gene electrotransfer in muscle, liver, tumor, and skin. Hum Gene Ther (2008) 1.39
Bleomycin: revival of an old drug. Gen Pharmacol (1996) 1.39
DNA electrotransfer: its principles and an updated review of its therapeutic applications. Gene Ther (2004) 1.37
Determination of the strange-quark density of the proton from ATLAS measurements of the W→ℓν and Z→ℓℓ cross sections. Phys Rev Lett (2012) 1.34
Search for new particles in two-jet final states in 7 TeV proton-proton collisions with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.32
Treatment of muscle injuries by local administration of autologous conditioned serum: a pilot study on sportsmen with muscle strains. Int J Sports Med (2004) 1.31
Enhancement of cytotoxicity by electropermeabilization: an improved method for screening drugs. Anticancer Drugs (1998) 1.30
Antitumor electrochemotherapy: new advances in the clinical protocol. Cancer (1996) 1.30
Observation of associated near-side and away-side long-range correlations in sqrt[s(NN)]=5.02 TeV proton-lead collisions with the ATLAS detector. Phys Rev Lett (2013) 1.27
Electrochemotherapy of spontaneous mammary tumours in mice. Eur J Cancer (1991) 1.26
In vivo electroporation of skeletal muscle: threshold, efficacy and relation to electric field distribution. Biochim Biophys Acta (1999) 1.24
Detergent structure and associated lipid as determinants in the stabilization of solubilized Ca2+-ATPase from sarcoplasmic reticulum. J Biol Chem (1989) 1.22
Search for dark matter candidates and large extra dimensions in events with a photon and missing transverse momentum in pp collision data at sqrt[s]=7 TeV with the ATLAS detector. Phys Rev Lett (2013) 1.19
Evolution of cell-mediated antitumor immunity in mice bearing a syngeneic chemically induced tumor. Influence of tumor growth, surgical removal and treatment with irradiated tumor cells. Int J Cancer (1972) 1.17
Electrochemotherapy tumor treatment is improved by interleukin-2 stimulation of the host's defenses. Eur Cytokine Netw (1992) 1.15
Search for a supersymmetric partner to the top quark in final states with jets and missing transverse momentum at sqrt[s] = 7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.13
The effect of pulse repetition frequency on the uptake into electropermeabilized cells in vitro with possible applications in electrochemotherapy. Bioelectrochemistry (2002) 1.11
Internalisation of the bleomycin molecules responsible for bleomycin toxicity: a receptor-mediated endocytosis mechanism. Biochem Pharmacol (1999) 1.10
Systemic antitumor effects of electrochemotherapy combined with histoincompatible cells secreting interleukin-2. J Immunother Emphasis Tumor Immunol (1995) 1.10
Effects of steroids and verapamil on P-glycoprotein ATPase activity: progesterone, desoxycorticosterone, corticosterone and verapamil are mutually non-exclusive modulators. Biochem J (1996) 1.10
Treatment of muscle injuries by local administration of autologous conditioned serum: animal experiments using a muscle contusion model. Int J Sports Med (2004) 1.09
A new brain tumour therapy combining bleomycin with in vivo electropermeabilization. Biochem Biophys Res Commun (1993) 1.09
Effects of phospholipids on binding of calcium to (Ca2(+)-Mg2(+)-ATPase. Biochemistry (1990) 1.08
Importance of association between permeabilization and electrophoretic forces for intramuscular DNA electrotransfer. Biochim Biophys Acta (2000) 1.08
Search for tb resonances in proton-proton collisions at √s=7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.07
Mechanism of inhibition of the (Ca2(+)-Mg2+)-ATPase by nonylphenol. Biochemistry (1990) 1.06
The ratio of single- to double-strand DNA breaks and their absolute values determine cell death pathway. Br J Cancer (2001) 1.06
Competitive and non-competitive inhibition of the multidrug-resistance-associated P-glycoprotein ATPase--further experimental evidence for a multisite model. Eur J Biochem (1997) 1.05
Search for a light Higgs boson decaying to long-lived weakly interacting particles in proton-proton collisions at sqrt[s] = 7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.05
Identification of a plasma membrane protein that specifically binds bleomycin. Biochem Biophys Res Commun (1993) 1.04
Role of pulse shape in cell membrane electropermeabilization. Biochim Biophys Acta (2003) 1.04
Multidrug resistance transporter P-glycoprotein has distinct but interacting binding sites for cytotoxic drugs and reversing agents. Biochem J (1998) 1.03
Relationships between DNA fragmentation, chromatin condensation, and changes in flow cytometry profiles detected during apoptosis. Exp Cell Res (1995) 1.03
Cell membrane electropermeabilization by symmetrical bipolar rectangular pulses. Part I. Increased efficiency of permeabilization. Bioelectrochemistry (2001) 1.01
A study of the immunological response to tumor ablation with irreversible electroporation. Technol Cancer Res Treat (2007) 1.01
Optimization of a gene electrotransfer method for mesenchymal stem cell transfection. Gene Ther (2008) 1.00
Electrochemotherapy in veterinary oncology. J Vet Intern Med (2008) 0.99
Search for supersymmetry in events with three leptons and missing transverse momentum in √[s]=7 TeV pp collisions with the ATLAS detector. Phys Rev Lett (2012) 0.99
Electrochemotherapy on liver tumours in rabbits. Br J Cancer (1998) 0.99
Membrane solubilization by detergent: use of brominated phospholipids to evaluate the detergent-induced changes in Ca2+-ATPase/lipid interaction. Biochemistry (1989) 0.99
Determination of optimal parameters for in vivo gene transfer by electroporation, using a rapid in vivo test for cell permeabilization. Biochem Biophys Res Commun (1999) 0.98
ATP regulation of sarcoplasmic reticulum Ca2+-ATPase. Metal-free ATP and 8-bromo-ATP bind with high affinity to the catalytic site of phosphorylated ATPase and accelerate dephosphorylation. J Biol Chem (1988) 0.97
Involvement of membrane bleomycin-binding sites in bleomycin cytotoxicity. Biochem Pharmacol (1994) 0.96
Search for the rare leptonic decay B--->tau-nutau. Phys Rev Lett (2005) 0.96
First clinical trial of cat soft-tissue sarcomas treatment by electrochemotherapy. Br J Cancer (1997) 0.96
Successful treatment of metastatic skin lesions with electrochemotherapy. J Urol (1998) 0.94
Apoptosis of tumoral and nontumoral lymphoid cells is induced by both mdm2 and p53 antisense oligodeoxynucleotides. Blood (2001) 0.94
DNA-drug recognition and effects on topoisomerase II-mediated cytotoxicity. A three-mode binding model for ellipticine derivatives. J Biol Chem (1991) 0.93
Cell membrane electropermeabilization by symmetrical bipolar rectangular pulses. Part II. Reduced electrolytic contamination. Bioelectrochemistry (2001) 0.93
Absence of cooperativity for MgATP and verapamil effects on the ATPase activity of P-glycoprotein containing membrane vesicles. Biochem Biophys Res Commun (1993) 0.92
Highly efficient oligonucleotide transfer into intact yeast cells using square-wave pulse electroporation. Biotechniques (1998) 0.92
Evolution of cell-mediated immunity in mice bearing tumors produced by a mammary carcinoma cell line. Influence of tumor growth, surgical removal, and treatment with irradiated tumor cells. J Natl Cancer Inst (1971) 0.89
Voltage-dependent introduction of a d[alpha]octothymidylate into electropermeabilized cells. Biochem Biophys Res Commun (1989) 0.88
Evaluation of cell membrane electropermeabilization by means of a nonpermeant cytotoxic agent. Biotechniques (2000) 0.87
Inhibition of tumor growth by histoincompatible cells expressing interleukin-2. Int Immunol (1992) 0.87
In vivo evolution of tumour cells after the generation of double-strand DNA breaks. Br J Cancer (2003) 0.87
Measurement of the ZZ production cross section and limits on anomalous neutral triple gauge couplings in proton-proton collisions at sqrt[s] = 7 TeV with the ATLAS detector. Phys Rev Lett (2012) 0.86
The metal sites on sarcoplasmic reticulum membranes that bind lanthanide ions with the highest affinity are not the ATPase Ca2+ transport sites. J Biol Chem (1992) 0.86